This compound releases Pano with temporal control in the oesophageal cancer cell line, OE21; it will be a useful research tool for those studying lysine acetylation and has the potential to allow the release of Pano while minimising off‐target effects.[35]. This evidence concerns the gene PANO1 and carcinoma of esophagus.